Urothelial cell carcinoma

Showing 9 of 0 results

• Flatiron Health attends the 2026 American Society of Genitourinary Cancers Symposium to answer oncology's most critical questions
  • Press releases
  • Urothelial cell carcinoma
  • Prostate cancer
• Real-world (rw) first-line (1L) treatment (tx) patterns and overall survival (rwOS) in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) with frailty or comorbidities

  ASCO GU

  • Publication summary
  • Publications
  • Treatment patterns
  • Urothelial cell carcinoma
• Opportunities for precision oncology: Real-world patterns and disparities in FGFR3 testing among US patients with locally advanced/metastatic urothelial cancer

  ASCO GU

  • Publication summary
  • Publications
  • Urothelial cell carcinoma
• Management and outcomes of rash, peripheral neuropathy, and hyperglycemia during first-line treatment of locally advanced/metastatic urothelial cancer in a real-world setting

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Urothelial cell carcinoma
• Real-world safety of first-line therapies for locally advanced or metastatic urothelial cancer in the US

  ASCO GU

  • Publication summary
  • Publications
  • Urothelial cell carcinoma
• Retrospective, observational analysis of real-world safety outcomes in sacituzumab govitecan-treated patients with locally advanced/metastatic urothelial cancer

  ASCO GU

  • Publication summary
  • Publications
  • Urothelial cell carcinoma
• Uptake of maintenance immunotherapy and changes in upstream treatment selection among patients with urothelial cancer

  JAMA Network Open

  • Publication summary
  • Publications
  • Treatment patterns
  • Urothelial cell carcinoma
• Systemic anticancer therapy at the end of life—changes in usage pattern in the immunotherapy era

  JAMA Oncology

  • Real-world evidence
  • Publication summary
  • Publications
  • Treatment patterns
  • Urothelial cell carcinoma
  • Melanoma
  • Non-small cell lung cancer
• Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapy

  Future Oncology

  • Publications
  • Comparative effectiveness
  • Urothelial cell carcinoma